Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis (Q34351552)

1 August 2017

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis (English)

1 reference

1 August 2017

ascending cholangitis

0 references

epidemiology

1 reference

primary sclerosing cholangitis

inferred from title

1 reference

2

Rinse K Weersma

1 reference

1 August 2017

15

Frank P Vleggaar

1 reference

1 August 2017

3

Karel J van Erpecum

1 reference

1 August 2017

Kirsten Boonstra

1

1 reference

1 August 2017

Erik A Rauws

4

1 reference

1 August 2017

B W Marcel Spanier

5

1 reference

1 August 2017

Alexander C Poen

6

1 reference

1 August 2017

Karin M van Nieuwkerk

7

1 reference

1 August 2017

Joost P Drenth

8

1 reference

1 August 2017

Ben J Witteman

9

1 reference

1 August 2017

Hans A Tuynman

10

1 reference

1 August 2017

Anton H Naber

11

1 reference

1 August 2017

Paul J Kingma

12

1 reference

1 August 2017

Henk R van Buuren

13

1 reference

1 August 2017

Bart van Hoek

14

1 reference

1 August 2017

Nan van Geloven

16

1 reference

1 August 2017

Ulrich Beuers

17

1 reference

1 August 2017

Cyriel Y Ponsioen

18

1 reference

1 August 2017

EpiPSCPBC Study Group

19

1 reference

1 August 2017

language of work or name

English

0 references

publication date

17 October 2013

1 reference

1 August 2017

1 reference

1 August 2017

58

1 reference

1 August 2017

2045-2055

1 reference

1 August 2017

6

1 reference

Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population

1 August 2017

1 reference

Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis

21 January 2018

1 reference

Four years experience with short term stenting in primary sclerosing cholangitis

21 January 2018

1 reference

Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis

21 January 2018

1 reference

Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis

21 January 2018

1 reference

Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study.

21 January 2018

1 reference

Immune-mediated diseases in primary sclerosing cholangitis

21 January 2018

1 reference

The geoepidemiology of primary biliary cirrhosis

21 January 2018

1 reference

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

21 January 2018

1 reference

Simplified criteria for the diagnosis of autoimmune hepatitis

21 January 2018

1 reference

Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review

21 January 2018

1 reference

Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.

21 January 2018

1 reference

Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community.

21 January 2018

1 reference

The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis.

21 January 2018

1 reference

Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.

21 January 2018

1 reference

Increasing incidence of inflammatory bowel diseases between 2000 and 2007: a nationwide register study in Finland

21 January 2018

1 reference

Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis

21 January 2018

1 reference

Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.

21 January 2018

1 reference

High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study

21 January 2018

1 reference

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis.

21 January 2018

1 reference

Effects of acetyl salycilic acid and ibuprofen in chronic liver damage induced by CCl4.

21 January 2018

1 reference

Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis

21 January 2018

1 reference

Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma

21 January 2018

1 reference

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

21 January 2018

1 reference

Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010.

21 January 2018

1 reference

Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years

21 January 2018

1 reference

Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease

21 January 2018

1 reference

Diagnosis and management of primary sclerosing cholangitis.

21 January 2018

1 reference

High lifetime risk of cancer in primary sclerosing cholangitis

21 January 2018

1 reference

7 January 2021

Natural history and prognostic variables in primary sclerosing cholangitis

1 reference

7 January 2021

IBD is associated with an increase in carcinoma in PSC irrespective of the presence of dominant bile duct stenosis

1 reference

7 January 2021

Classification of inflammatory bowel disease

1 reference

7 January 2021

Prevalence of autoimmune liver disease in Alaska Natives

1 reference

7 January 2021

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

7 January 2021

Cyclooxygenases in hepatocellular carcinoma.

1 reference

7 January 2021

Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.26565

1 reference

release_dygvlxbxlrgfpdwh6plhwpitn4

1 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dygvlxbxlrgfpdwh6plhwpitn4

24 November 2022

mapped directly with Wikidata item

1 reference